Thermo Fisher Scientific Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Corporation WALTHAM, Mass., Nov. 21, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it received notice of an unsolicited “mini-tender” offer by TRC Capital Corporation (TRC) to purchase up to 1,000,000 shares of Thermo... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Citi Global Healthcare Conference on Wednesday, December 6, 2017 10:15 a.m. ET at the Lotte New York Palace in New York City. Andy Wilson, PerkinElmer’s chief financial officer, will... Read more
ELRIG honors Labcyte with its Technology Prize November 21, 2017 SAN JOSE, CA Labcyte Inc. today announced that its Echo® Acoustic Mass Spectrometry platform was awarded the Technology Prize during the European Laboratory Research & Innovation Group’s (ELRIG) annual Drug Discovery event in Liverpool, UK. The award was presented by ELRIG Chairman Steve Rees during the... Read more
MORRIS PLAINS, N.J., Nov. 20, 2017 /PRNewswire/ — Honeywell (NYSE: HON) today announced the final results of its previously announced four separate private offers to exchange any and all of its outstanding notes listed below (the “Existing Notes”), for a combination of Honeywell’s newly issued 3.812% Senior Notes due 2047 and cash (the “Exchange Offers”). The Exchange Offers... Read more
Basel, 20 November 2017 Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer Data will be submitted to health authorities globally, including the US Food and Drug Administration (FDA)... Read more
Basel, 20 November 2017 Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer Data will be submitted to health authorities globally, including the US Food and Drug Administration (FDA)... Read more
CHELMSFORD, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the company will present at the Credit Suisse 21st Annual Technology, Media & Telecom Conference at the Phoenician, Scottsdale, AZ. Lindon Robertson, Chief Financial Officer, will present on Thursday, November 30th at 10:00 a.m. Mountain Time. Analysts, investors and members... Read more
Download PDF Read more
AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017. The presentation will be webcast live... Read more
AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017. The presentation will be webcast live... Read more